Normalcy of Food Intake in Head and Neck Cancer Patients
FOCISD
1 other identifier
interventional
120
1 country
1
Brief Summary
- Background: Oral nutrition appears to be a challenge for patients with head and neck cancer after radiotherapy. Many patients desire to (their) 'normal food intake' and return to oral nutrition with normal consistency without modifications and diet formulas. Due to the dysphagia experienced post treatment this seems tremendously difficult. Referral to a speech-language therapist for swallowing therapy is no standard procedure.
- Study design: A prospective randomized study in patients with a tumor in Oral cavity, Nasopharynx, Oropharynx, Hypopharynx or Larynx with stage II-IV (UICC TNM-tumor classification), ≥ 18 years, eligible for primary treatment with (chemo)radiation or adjuvant radiotherapy with curative intent.
- Intervention: Individually tailored swallowing therapy by an experienced speech-language therapist in cooperation with individual dietary counselling (by an experienced dietician, 'usual care') pre-, per- and post treatment (until 6 months after treatment). This might improve 'normalcy of food intake', quality (no food modifications) and quantity of food intake and besides decrease the use of tube feeding and/or nutritional supplements. Also patients quality of life and nutritional status may be influenced positively.
- Study hypothesis: The purpose of this study is to determine whether combined individual swallowing therapy and individual dietary counselling in patients with head and neck cancer receiving (chemo)radiotherapy can improve 'normal food intake'. Food intake without modifications and tube feeding and/or nutritional supplements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 23, 2010
CompletedFirst Posted
Study publicly available on registry
April 27, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMay 22, 2013
October 1, 2012
2.8 years
April 23, 2010
May 21, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Normalcy of food intake
Increase of "normalcy of food intake" of 10%
within 6 months
Secondary Outcomes (1)
Quality of life
within 6 months
Study Arms (2)
Swallowing therapy
EXPERIMENTALSwallowing therapy in combination with individual dietary counselling
Individual dietary counselling
ACTIVE COMPARATORSwallowing therapy only on indication. (usual care)
Interventions
Weekly swallowing therapy (by speech language therapist) from start of (chemo)radiation until 6 months after last (chemo)radiation. Weekly Individual dietary counselling (by dietician) form the start of (chemo) radiotherapy until 6 months after last (chemo)radiation. With close interaction between the both interventions.
Weekly Individual dietary counselling form the start of (chemo) radiotherapy until 6 months after last (chemo)radiation.
Eligibility Criteria
You may qualify if:
- Patients with tumor in oral cavity, nasopharynx, hypopharynx or larynx with stage II-IV (UICC TNM-tumor classification)
- Eligible for primary curative treatment intentions with (chemo)radiation or adjuvant (chemo)radiotherapy
- A signed informed consent
You may not qualify if:
- Historical swallowing problems (neurological or not tumor related)
- Unable to comprehend and carry out the swallowing rehabilitation
- Unable to answer study questions
- Radiation or surgery for head and neck cancer in history.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Radboud University Medical Centerlead
- Sorgente BVcollaborator
- Fresenius Kabi Nederland BVcollaborator
Study Sites (1)
Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, 6500 HB, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mattias A. W. Merkx, Prof. Dr.
Radboud University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2010
First Posted
April 27, 2010
Study Start
March 1, 2010
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
May 22, 2013
Record last verified: 2012-10